
NOVT
Novanta Inc
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
106.290
Open
106.290
VWAP
103.74
Vol
3.89M
Mkt Cap
3.77B
Low
101.440
Amount
403.05M
EV/EBITDA(TTM)
23.21
Total Shares
35.78M
EV
4.14B
EV/OCF(TTM)
35.42
P/S(TTM)
3.96
Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
260.30M
+7.99%
0.890
+17.11%
255.40M
+9.44%
0.840
+13.51%
255.59M
+7.36%
0.900
+18.42%
Estimates Revision
The market is revising No Change the revenue expectations for Novanta Inc. (NOVT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -8.84%.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Stock Price
Go Down

-8.84%
In Past 3 Month
2 Analyst Rating
Wall Street analysts forecast NOVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NOVT is 133.00 USD with a low forecast of 133.00 USD and a high forecast of 133.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 105.450
Low
133.00
Averages
133.00
High
133.00
Current: 105.450
Low
133.00
Averages
133.00
High
133.00
Baird
Neutral
downgrade
$139 -> $133
2025-08-11
Reason
Baird
Price Target
$139 -> $133
2025-08-11
downgrade
Neutral
Reason
Baird lowered the firm's price target on Novanta to $133 from $139 and keeps a Neutral rating on the shares. The firm updated its model as it believes the sales bottom looks in place and the outlook for 2026 looks potentially favorable.
Baird
Baird
Neutral
downgrade
$160 -> $139
2025-05-12
Reason
Baird
Baird
Price Target
$160 -> $139
2025-05-12
downgrade
Neutral
Reason
Baird lowered the firm's price target on Novanta to $139 from $160 and keeps a Neutral rating on the shares. The firm updated its model following mixed Q1 results where they lowered estimates but see bright spots beginning to appear.
Baird
Robert Mason
Hold
Maintains
$169 → $160
2025-03-03
Reason
Baird
Robert Mason
Price Target
$169 → $160
2025-03-03
Maintains
Hold
Reason
Baird analyst Robert Mason lowered the firm's price target on Novanta to $160 from $169 and keeps a Neutral rating on the shares. The firm The firm updated its model following its mixed Q4 report. New products are driving the 2025 outlook which with upside possible if markets rebound.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Novanta Inc (NOVT.O) is 29.21, compared to its 5-year average forward P/E of 47.72. For a more detailed relative valuation and DCF analysis to assess Novanta Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Strongly Undervalued
5Y Average PE
47.72
Current PE
29.21
Overvalued PE
55.43
Undervalued PE
40.02
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
28.79
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
33.35
Undervalued EV/EBITDA
24.24
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
6.82
Current PS
105.45
Overvalued PS
16.96
Undervalued PS
-3.32
Financials
Annual
Quarterly
FY2025Q3
YoY :
+1.40%
247.84M
Total Revenue
FY2025Q3
YoY :
-18.63%
28.53M
Operating Profit
FY2025Q3
YoY :
-44.49%
10.65M
Net Income after Tax
FY2025Q3
YoY :
-43.40%
0.30
EPS - Diluted
FY2025Q3
YoY :
-78.36%
4.21M
Free Cash Flow
FY2025Q3
YoY :
-0.07%
41.96
Gross Profit Margin - %
FY2025Q3
YoY :
-14.15%
10.68
FCF Margin - %
FY2025Q3
YoY :
-45.22%
4.30
Net Margin - %
FY2025Q3
YoY :
-24.64%
5.81
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
955.5K
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 140% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
2
120.0K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
8.0K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
8.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
955.5K
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
NOVT News & Events
Events Timeline
2025-11-05 (ET)
2025-11-05
16:17:10
Novanta Reveals Plan to Offer 11 Million Tangible Equity Units
2025-11-03 (ET)
2025-11-03
17:02:26
Novanta Revises FY25 Adjusted EPS Range to $3.24-$3.30 from $3.22-$3.36
2025-11-03
17:01:27
Novanta projects Q4 adjusted EPS between 87c and 93c, below consensus estimate of 94c.
Sign Up For More Events
Sign Up For More Events
News
8.5
11-07NewsfilterPinnedNovanta Inc. Reveals Pricing for $550 Million Tangible Equity Units Offering
9.5
10-30NASDAQ.COMOSI Systems (OSIS) Exceeds Q1 Earnings and Revenue Projections
5.0
10-26NASDAQ.COMGrowth Fund Offloads $20 Million in Novanta Shares Amidst Challenging Market Conditions
Sign Up For More News
People Also Watch

HXL
Hexcel Corp
69.130
USD
+0.01%

VLY
Valley National Bancorp
11.050
USD
+2.31%

GXO
GXO Logistics Inc
50.840
USD
+0.04%

NSIT
Insight Enterprises Inc
91.210
USD
-0.36%

CRUS
Cirrus Logic Inc
118.640
USD
+0.02%

MAIN
Main Street Capital Corp
58.700
USD
+2.71%

INSP
Inspire Medical Systems Inc
81.790
USD
-2.41%

BIPC
Brookfield Infrastructure Corp
45.330
USD
-2.37%

FRSH
Freshworks Inc
11.190
USD
+3.13%

FFIN
First Financial Bankshares Inc
31.350
USD
+1.95%
FAQ
What is Novanta Inc (NOVT) stock price today?
The current price of NOVT is 105.45 USD — it has decreased -1.69 % in the last trading day.





